Stock·NYSE·Technology
D-Wave Quantum Inc. (QBTS)
- Market cap
- $4.38B
- Dividend yield
- None
- Street target
- $36.00median of 17 analysts
- 52-week range
- $11.26 $37.62
QBTS stock forecast today
Where QBTS stands today, and what CleaRank Financial AI makes of it.
QBTS at a glance
D-Wave Quantum Inc. (QBTS): Sell, 25/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($16.09 and $19.64).
- Earnings QBTS beat estimates in 3 of the 6 reports in our data, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $152.9M and bought $2K over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates D-Wave Quantum Inc. (QBTS) Sell, with a model score of 25/100.
The biggest support comes from the analysts' outlook: 15 of 17 analysts rate it a buy, and the median target is 212.0% above the price. The trend is the largest drag. The price is 41.24% below its 200-day average and 28.30% below its 50-day, while the 50-day sits 18.05% below the 200-day. The 50-day average is $16.09 and the 200-day is $19.64. Across the past year the price has fallen 64.66%.
Only on CleaRank
Figures we compute ourselves from QBTS's own price, earnings and insider-filing history. Tap one to see it in context.
QBTS stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $11.54 is 28.3% below the 50-day simple moving average of $16.09.Price above its 200-day average ›
The price is 41.2% below the 200-day simple moving average of $19.64.50-day average above the 200-day ›
The 50-day average ($16.09) is 18.0% below the 200-day average ($19.64), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $11.26 and $37.62.
QBTS share price
Pick a period: each tab shows how far QBTS has moved over it, to the last close.
Today's trading
Where QBTS sits inside today's range and its 52-week range.
QBTS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/3P/S below the sector median ›
The price-to-sales ratio of 352.59 is 4,539.3% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was -$248.7M on revenue of $12.4M, a net margin of -2,001.6%.Beat estimates in most recent reports ›
QBTS beat the EPS estimate in 3 of the 6 reports in our data.
Key statistics
The headline figures for QBTS.
As of October 26, 2026, QBTS trades at $11.54, with a market value of $4.38B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of QBTS's valuation, growth and risks.
A P/E cannot be read for D-Wave Quantum Inc. (QBTS): it is not meaningful, because its earnings per share over the last 12 months are negative. For scale, QBTS carries a market capitalisation of $4.4B and trailing earnings of -$0.69 a share.
The company is losing money, with a net margin of -2,001.59% and an operating margin of -1,732.06%. With a revenue decline of 0.60%, QBTS is 24.8 percentage points slower than the sector median of 24.2%. It generates a return on equity of -27.99%, below the sector median of 13.4%. The balance sheet rounds out the picture, with debt-to-equity of 0.04.
In its last earnings report, on August 6, 2026, QBTS reported EPS of -$0.13 against an estimate of -$0.09, a worse result than analysts expected. Even so, the share price rose 6.98% in the first session after the report.
QBTS beat estimates in 3 of the 6 reports in our data, yet the stock fell in the first session after 1 of those 3 beats. The sharpest earlier reaction followed the May 12, 2026 report: EPS beat the estimate by 37.50%, but the share price dropped 4.07%. For this fiscal year, analysts average an EPS estimate of -$0.29, and for next year -$0.38.
On a typical day the price of QBTS shifts by 3.91%, the 30-day standard deviation of its daily returns, and its beta against the S&P 500 is 2.17. Until the price regains its moving averages, the trend works against holders. The price is 69.32% below its 52-week high of $37.62.
QBTS against the Technology sector
How QBTS compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, QBTS trades at 352.59x, far above the sector average of 7.60x.
Return vs XLK: Since May 14, 2025, QBTS has gained 4.2% against a gain of 59.2% for XLK.
Performance against XLK
QBTS and the Technology sector fund over the same days.
Revenue and earnings
How much QBTS sells, and how much of it becomes profit.
Revenue growth: Revenue grew 178.5% in FY2025 to $24.6M, from $8.8M a year earlier.
Profit margin: The net margin was -1,444.1% in FY2025, up from -1,630.0% the year before.
Loss-making: QBTS lost $355M in FY2025.
Earnings reality check
Did QBTS beat what analysts expected, and how did the stock react?
Earnings record: QBTS beat the analyst estimate in 3 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 1 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | -$0.09 | -$0.13 | -44.44% | +6.98% | +7.70% |
| May 12, 2026after close | -$0.08 | -$0.05 | +37.50% | -4.07% | -18.61% |
| Nov 6, 2025after close | -$0.07 | -$0.05 | +28.57% | +3.91% | -17.61% |
| Aug 7, 2025after close | -$0.05 | -$0.08 | -60.00% | -1.57% | +5.88% |
| May 8, 2025after close | -$0.04 | -$0.03 | +25.00% | +6.43% | +5.85% |
| Nov 14, 2024after close | -$0.08 | -$0.10 | -25.00% | -12.30% | +5.35% |
As of October 26, 2026, QBTS has beaten the analyst EPS estimate in 3 of the 6 reports in our data and fell in the first trading session after 1 of those beats; its latest report, on August 6, 2026, came in 44.44% below the estimate and the stock moved +6.98% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
QBTS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 27.8, in oversold territory.RSI above 50 ›
An RSI of 27.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of QBTS
The score, the reasoning behind it, and what could move the price next.
QBTS, the stock of D-Wave Quantum Inc., is in a downtrend: at $11.54 it is 41.24% below its 200-day average of $19.64 and 28.30% below its 50-day average of $16.09. Its price is near the floor of its 52-week range, 2.49% above the low of $11.26, while sitting 69.32% below the high of $37.62. The 50-day average is 18.05% below the 200-day, a configuration that backs up the weak trend instead of cutting against it.
The 14-day RSI of 27.8 is in oversold territory, and the MACD line is negative. The recent returns are all negative: the price fell 40.85% over the past three months, fell 38.62% over the past six months and fell 64.66% over the past year. Volume in the last session ran 39.4% below its average, on a day the price fell 1.03%.
New analyst coverage ›
Benchmark started coverage at Buy on July 27, 2026.
Source: Analyst action, Benchmark, July 27, 2026Rating reaffirmed ›
Rosenblatt kept its Buy rating on August 7, 2026.
Source: Analyst action, Rosenblatt, August 7, 2026
Earnings miss, but the stock rose ›
The August 6, 2026 report missed the EPS estimate by 44.44%, and the share price rose 6.98% in the first session after it.
Source: Earnings report, August 6, 2026
- The two closest levels deserve attention: the 20-day EMA at $13.44 sits above the price, and the 52-week low at $11.26 sits below it.
- A 14-day RSI of 27.8 places the stock in oversold territory, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- Following the August 6, 2026 report, the share price went up 6.98% in the first session. Over the 6 reports in our data, QBTS has beaten estimates 3 times.
QBTS is trading below its 50-day and 200-day moving averages ($16.09 and $19.64), and that keeps the trend pointing down. A first sign of repair would be a move back above the 50-day. The closest level above the price is the 20-day EMA, at $13.44.
The 52-week low at $11.26 is the next level below. Momentum is washed out, with the RSI below the oversold line; a turn back above it would be an early sign of stabilising.
Technical indicators
Momentum and trend for QBTS, from its daily closes.
As of October 26, 2026, with QBTS at $11.54, its 14-day RSI is 27.8 (oversold territory), its 50-day simple moving average is $16.09 and its 200-day is $19.64.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What QBTS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, QBTS's 1-year correlation of daily returns is +0.33 with S&P 500 (SPY), +0.37 with Nasdaq 100 (QQQ), +0.45 with Bitcoin (BTC) and +0.20 with gold (XAU).
QBTS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
15 of 17 analysts rate it a buy or strong buy, 2 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $36.00 is 212.0% above the price.More buy ratings than three months ago ›
15 of 17 rate it a buy now, against 15 of 16 three months ago.
QBTS Wall Street View
12-month price targets
The price, $11.54, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 7, 2026 | Rosenblatt | Maintains | Buy |
| Jul 28, 2026 | Rosenblatt | Maintains | Buy |
| Jul 27, 2026 | Benchmark | Initiates | Buy |
| Jun 15, 2026 | Mizuho | Maintains | Outperform |
| Jun 11, 2026 | Rosenblatt | Maintains | Buy |
| Jun 2, 2026 | B. Riley Securities | Maintains | Buy |
As of October 26, 2026, 17 Wall Street analysts cover QBTS: 15 rate it a buy or strong buy, 2 a hold and 0 a sell or strong sell. Their 12-month price targets range from $18.36 to $43.00. The median QBTS price target is $36.00, 212.0% above the price of $11.54.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
QBTS trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
QBTS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
QBTS moves about 3.9% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much QBTS tends to move, against the market and on its own.
QBTS price history and drawdowns
QBTS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 3.91% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 96.2%, from February 2021 to May 2023, regained by May 2025.Most 1-year holds ended higher ›
50% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in December 2020 is now worth $11,369, against $22,649 in the S&P 500 (SPY).
QBTS Drawdowns & Recovery
As of October 26, 2026, QBTS's worst peak-to-trough fall over the last 6 years with dividends reinvested was -96.2% (February 2021 to May 2023); it regained that peak by May 2025, 24 months after the low, and 50% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into QBTS in December 2020 is worth now, against the same amount in the S&P 500.
Against the market: QBTS trailed the S&P 500 over this period: $11,369 against $22,649.
A $10,000 investment in QBTS in December 2020 would be worth about $11,369 today with dividends reinvested, compared with about $22,649 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to QBTS, and which have not.
Strongest month, December: an average of +50.59%, up in 3 of 5 years.
Weakest month, January: an average of -13.08%, up in 0 of 6 years.
This month, October: has averaged -3.23%, up in 3 of 5 years. Past seasonality does not repeat on schedule.
Over the last 6 years, QBTS's strongest calendar month has been December (average +50.59%, up in 3 of 5 years) and its weakest January (average -13.08%, up in 0 of 6 years).
Average return for each calendar month over the last 6 years, from weekly closing prices with dividends included.
QBTS stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in QBTS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 6 years of price history, projects that a $10,000 investment in QBTS today could grow to about $11,847 by 2030 in the base case, with a 90th-percentile outcome near $42,676 and a 10th-percentile outcome around $3,289. Projections are statistical simulations, not guarantees.
QBTS Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $13.67 for QBTS by 2030 in the base case, from $11.54 today (1.2x over 4 years). The 10th-percentile path ends near $3.79. These are outcomes of a Monte Carlo simulation run on QBTS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $6.34 | $12.04 | $22.85 | |
| 2028 | $5.07 | $12.56 | $31.09 | |
| 2029 | $4.32 | $13.10 | $39.76 | |
| 2030 | $3.79 | $13.67 | $49.25 |
Method: a lognormal simulation of QBTS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
QBTS insider trading
What the people running the company have bought and sold.
QBTS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $2K on the open market and sold $152.9M.
As of October 26, 2026, QBTS insiders reported 51 open-market sales worth $152.9M and 1 open-market purchase worth $2K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Bernard Gavgani
Director
|
Grant | 16.5K | - |
| Sep 8, 2026 | John David Dilullo
Director
|
Sell | 1.1K | $19.8K |
| Jul 20, 2026 | Sophie C Ames
Officer
|
Sell | 3.1K | $52.0K |
| Jun 15, 2026 | John M Markovich
Chief Financial Officer
|
Sell | 246.0K | $6.2M |
| Jun 15, 2026 | Rohit Ghai
Director
|
Sell | 13.5K | $357.1K |
| Jun 9, 2026 | John M Markovich
Chief Financial Officer
|
Sell | 51.0K | $1.3M |
| Jun 8, 2026 | Alan E Baratz
Chief Executive Officer
|
Sell | 687.6K | $18.0M |
| Jun 8, 2026 | Alan E Baratz
Chief Executive Officer
|
Option | 687.6K | $612.1K |
| Jun 5, 2026 | John David Dilullo
Director
|
Sell | 7.9K | $191.8K |
| Jun 4, 2026 | Roger Biscay
Director
|
Grant | 9.4K | - |
| Jun 4, 2026 | John David Dilullo
Director
|
Grant | 9.4K | - |
| Jun 4, 2026 | Rohit Ghai
Director
|
Grant | 9.4K | - |
| Jun 4, 2026 | Sharon E Holt
Director
|
Grant | 9.4K | - |
| Jun 4, 2026 | Kirstjen Nielsen
Director
|
Grant | 9.4K | - |
| Jun 4, 2026 | Steven M. West
Director
|
Grant | 9.4K | - |
| Jun 2, 2026 | John M Markovich
Chief Financial Officer
|
Sell | 2.9K | $90.1K |
| May 22, 2026 | John M Markovich
Chief Financial Officer
|
Sell | 328.8K | $9.1M |
| May 22, 2026 | John M Markovich
Chief Financial Officer
|
Option | 328.8K | $293.5K |
| May 21, 2026 | Diane Nguyen
General Counsel
|
Sell | 40.0K | $1.0M |
| May 20, 2026 | Sophie C Ames
Officer
|
Sell | 23.0K | $436.9K |
| Apr 30, 2026 | Alan E Baratz
Chief Executive Officer
|
Grant | 753.9K | - |
| Apr 20, 2026 | Sophie C Ames
Officer
|
Sell | 3.1K | $65.5K |
| Mar 16, 2026 | Rohit Ghai
Director
|
Sell | 10.0K | $176.2K |
| Mar 13, 2026 | John M Markovich
Chief Financial Officer
|
Sell | 10.7K | $188.7K |
| Mar 13, 2026 | Diane Nguyen
General Counsel
|
Sell | 2.5K | $44.6K |
| Mar 5, 2026 | John David Dilullo
Director
|
Sell | 8.0K | $144.1K |
| Feb 19, 2026 | Diane Nguyen
General Counsel
|
Grant | 28.1K | - |
| Feb 13, 2026 | Diane Nguyen
General Counsel
|
Sell | 1.5K | $28.7K |
| Jan 14, 2026 | Alan E Baratz
Chief Executive Officer
|
Sell | 35.0K | $982.5K |
| Jan 14, 2026 | Diane Nguyen
General Counsel
|
Sell | 24.5K | $704.0K |
| Jan 14, 2026 | John M Markovich
Chief Financial Officer
|
Sell | 9.2K | $257.6K |
| Dec 22, 2025 | Alan E Baratz
Chief Executive Officer
|
Sell | 793.7K | $23.9M |
| Dec 22, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 100.0K | $3.0M |
| Dec 22, 2025 | Alan E Baratz
Chief Executive Officer
|
Option | 793.7K | $722.3K |
| Dec 22, 2025 | John M Markovich
Chief Financial Officer
|
Option | 100.0K | $92.0K |
| Dec 15, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 11.6K | $276.3K |
| Dec 15, 2025 | Rohit Ghai
Director
|
Sell | 10.0K | $242.8K |
| Dec 15, 2025 | Diane Nguyen
General Counsel
|
Sell | 2.7K | $65.3K |
| Dec 5, 2025 | John David Dilullo
Director
|
Sell | 8.0K | $218.9K |
| Dec 4, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 200.0K | $5.3M |
| Dec 4, 2025 | John M Markovich
Chief Financial Officer
|
Option | 200.0K | $184.0K |
| Dec 3, 2025 | Kirstjen Nielsen
Director
|
Sell | 7.0K | $158.3K |
| Nov 21, 2025 | John David Dilullo
Director
|
Grant | 492 | - |
| Nov 20, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 200.0K | $4.6M |
| Nov 20, 2025 | John M Markovich
Chief Financial Officer
|
Option | 200.0K | $184.0K |
| Nov 18, 2025 | Steven M. West
Director
|
Buy | 82 | $1.8K |
| Nov 13, 2025 | Alan E Baratz
Chief Executive Officer
|
Sell | 168.1K | $3.9M |
| Nov 13, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 98.1K | $2.3M |
| Nov 13, 2025 | Diane Nguyen
General Counsel
|
Sell | 22.8K | $538.2K |
| Nov 11, 2025 | Alan E Baratz
Chief Executive Officer
|
Sell | 806.3K | $23.3M |
| Nov 11, 2025 | Alan E Baratz
Chief Executive Officer
|
Option | 806.3K | $733.7K |
| Oct 14, 2025 | Alan E Baratz
Chief Executive Officer
|
Sell | 31.4K | $1.4M |
| Oct 14, 2025 | Diane Nguyen
General Counsel
|
Sell | 20.8K | $911.0K |
| Oct 14, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 8.0K | $349.7K |
| Sep 15, 2025 | Rohit Ghai
Director
|
Sell | 10.0K | $179.3K |
| Sep 15, 2025 | John David Dilullo
Director
|
Sell | 8.0K | $143.4K |
| Sep 12, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 150.0K | $2.5M |
| Sep 12, 2025 | John M Markovich
Chief Financial Officer
|
Option | 150.0K | $138.0K |
| Sep 5, 2025 | John M Markovich
Chief Financial Officer
|
Option | 40.8K | $37.5K |
| Aug 13, 2025 | Steven M. West
Director
|
Sell | 144.0K | $2.6M |
| Aug 13, 2025 | Diane Nguyen
General Counsel
|
Sell | 69.3K | $1.3M |
| Aug 13, 2025 | Diane Nguyen
General Counsel
|
Option | 79.8K | $121.3K |
| Aug 12, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 100.0K | $1.8M |
| Aug 12, 2025 | John M Markovich
Chief Financial Officer
|
Option | 100.0K | $92.0K |
| Aug 5, 2025 | Steven M. West
Director
|
Grant | 237.8K | - |
| Jul 31, 2025 | Diane Nguyen
Officer
|
Grant | 16.1K | - |
| Jun 16, 2025 | Kirstjen Nielsen
Director
|
Sell | 71.6K | $1.2M |
| Jun 16, 2025 | John David Dilullo
Director
|
Sell | 57.0K | $902.8K |
| Jun 12, 2025 | Roger Biscay
Director
|
Sell | 106.6K | $1.8M |
| Jun 12, 2025 | Rohit Ghai
Director
|
Sell | 43.5K | $731.3K |
| Jun 5, 2025 | Roger Biscay
Director
|
Grant | 14.3K | - |
| Jun 5, 2025 | John David Dilullo
Director
|
Grant | 14.3K | - |
| Jun 5, 2025 | Rohit Ghai
Director
|
Grant | 14.3K | - |
| Jun 5, 2025 | Sharon E Holt
Director
|
Grant | 14.3K | - |
| Jun 5, 2025 | Kirstjen Nielsen
Director
|
Grant | 14.3K | - |
| Jun 5, 2025 | Steven M. West
Director
|
Grant | 21.7K | - |
| May 23, 2025 | Diane Nguyen
General Counsel
|
Sell | 85.8K | $1.6M |
| May 23, 2025 | Diane Nguyen
General Counsel
|
Option | 141.4K | $143.8K |
| May 22, 2025 | Roger Biscay
Director
|
Sell | 112.2K | $2.0M |
| May 21, 2025 | Alan E Baratz
Chief Executive Officer
|
Sell | 845.8K | $14.4M |
| May 21, 2025 | John M Markovich
Chief Financial Officer
|
Sell | 400.0K | $6.9M |
| May 21, 2025 | Steven M. West
Director
|
Sell | 312.0K | $5.1M |
| May 21, 2025 | Alan E Baratz
Chief Executive Officer
|
Option | 845.8K | $769.7K |
| May 21, 2025 | John M Markovich
Chief Financial Officer
|
Option | 502.7K | $462.5K |
| May 21, 2025 | Steven M. West
Director
|
Option | 312.0K | $284.8K |
| May 1, 2025 | Alan E Baratz
Chief Executive Officer
|
Grant | 580.1K | - |
Source: TwelveData, from SEC Form 4 filings
QBTS stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.